Documents

Displaying 9701 - 9707 of 9707

Use this document to submit brand price change for drugs listed on the Yukon Drug Formulary. View the Yukon Drug Formulary. 

81-106 National Instrument, Investment Fund Continuous Disclosure, Securities Act, Amendment Effective March 3, 2025.

81-101 National Instrument, Mutual Fund Prospectus Disclosure, Amendment Effective March 3, 2025.

41-101 National Instrument, General Prospectus Requirements, Amendment Effective March 3, 2025.

Was this page helpful?